PML and hematopoietic and lymphoid cell neoplasm: Additionally, since PML contributes to hematopoietic cancer stem cell self-renewal and the aggressiveness of triple-negative breast cancer, directly reducing PML protein levels seems to be a promising strategy to treat some types of cancers.